Search
for
Sort by
Research 151–180 of 567
- Hormone therapy in acne
- Hair Loss in Systemic Disease
- Contraception and the dermatologist
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Alopecia in Epidermolysis Bullosa
- Hair and Nail Relationship
- An Update on Drug-Induced Pigmentation
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- Hair and nail involvement in lupus erythematosus
- Cocaine-related bullous disease
- Cosmetic potential of Southeast Asian herbs: an overview
- Kawasaki disease: an update
- Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Lucio Phenomenon: Sequelae of Neglected Leprosy
- Alopecia-associated pseudocyst of the scalp
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Common Dermatologic Disorders in Down Syndrome: Systematic Review
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- The correlation between alopecia and temperament in rhesus macaques (<i>Macaca mulatta</i>) at four primate facilities
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Dermoscopy: not just for dermatologists
- Focal and Generalized Alopecia
- Skin disorders associated with the COVID‐19 pandemic: A review
- Pellagra and anorexia nervosa: a case report
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Hair shaft miRNA‐221 levels as a new tumor marker of malignant melanoma